Brazil's medtech, drug companies to comment on government regs

02/20/2013 | Clinica

Anvisa, Brazil's regulatory agency for health care products, is giving the industry an opportunity to comment on its review procedures and regulations for 2013-2014. The consultation process encompasses more than 200 of Brazil's health care groups, including associations for medical device importers, implant manufacturers and dealers, and diagnostic laboratories.

View Full Article in:

Clinica

Published in Brief:

SmartBrief Job Listings for Health Care